TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

1.80$ -0.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Tenax Therapeutics Inc (TENX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -36 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TENX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-9.3 -9.7 -16 -12 -5.5 -7.6 -9.3 -11 -12 -5.9 -15 -36
0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 –
0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 1.1 19
1.6 1.3 25 0.4 0.6 0.3 0.4 22 – – – –
-1.5 1.9 1.9 -3.9 0.6 0.5 0.1 -0.6 -1.4 1.6 1.6 -2.4
0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-41 -41 22 3.7 7.4 0.0 0.0 0.5 0.0 0.0 – –
0.0 – 0.0 0.0 7.3 – – – – – – –
0.5 – 0.0 0.0 8.9 0.1 10 – – – – –
-0.3 -0.2 – 0.2 0.2 0.2 0.2 0.0 0.0 -0.6 -0.5 0.0
67 0.3 0.3 0.5 8.9 0.1 11 9.7 8.6 14 100 39
58 -50 6.3 -8.4 11 -7.5 1.3 -0.7 -3.5 7.7 85 2.7
-9.4 -9.9 -16 -12 -5.5 -7.6 -9.3 -11 -12 -5.9 -15 -36

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?